Sri Lakshmi Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.30 Cr
- Revenue Growth %
- Net Worth 1864.20%
- Total Assets 64409.40%
About Sri Lakshmi Pharma
Sri Lakshmi Pharma Private Limited (SLPPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 April 2021 (Three years and nine months 21 days old ). Its registered office is in Mysore, Karnataka, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.30 Cr.
Laxmeesha and Sowmya Laxmeesha serve as directors at the Company.
Company Details
-
Location
Mysore, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24299KA2021PTC146590
-
Company No.
146590
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Apr 2021
-
Date of AGM
25 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Sri Lakshmi Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Laxmeesha
|
Director | 15-Apr-2021 | Current |
|
Sowmya Laxmeesha
|
Director | 15-Apr-2021 | Current |
Financial Performance of Sri Lakshmi Pharma.
Sri Lakshmi Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 1864.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sri Lakshmi Pharma?
Unlock access to Sri Lakshmi Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Needs Natura Pharmaceuticals LlpLaxmeesha is a mutual person
Charges (Loans)
₹33.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 3.20 Cr
- Hdfc Bank Limited : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Jun 2024 | Hdfc Bank Limited | ₹1.00 M | Open |
| 22 Apr 2022 | State Bank Of India | ₹3.20 Cr | Open |
How Many Employees Work at Sri Lakshmi Pharma?
Sri Lakshmi Pharma has a workforce of 15 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sri Lakshmi Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sri Lakshmi Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.